Lyell Immunopharma, Inc.

LYEL

—

Advanced chart & tools →

Lyell Immunopharma, Inc.LYEL

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-16.06

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$36,000

Net income

$-274.45M

Net margin

-762355.6%

Gross margin

—

Dividends & financials

Lyell Immunopharma, Inc. (LYEL) reported revenue of $36,000 and net income of $-274.45M, or $-16.06 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.